Department of Surgery, Anesthesiology, and Radiology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt.
Department of Internal Medicine, Infectious and Fish Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35516, Egypt.
BMC Vet Res. 2022 Jul 14;18(1):274. doi: 10.1186/s12917-022-03376-4.
Gastrointestinal effects of different doses of dexmedetomidine in donkeys are still unidentified. The current study aimed to evaluate the impact of different doses of dexmedetomidine on the motility of selected parts of the gastrointestinal tracts in donkeys using transabdominal ultrasonography.
An experimental crossover study was conducted on 30 healthy donkeys of both sexes (15 males and 15 females; 160 ± 60 kg). With a two-week washout period, each donkey received an injection of either a normal saline solution or three different doses of dexmedetomidine (3, 5, and 7 μg/kg, respectively). All medications were administered intravenously in equal volumes. The contractility of selected intestinal segments (duodenum, jejunum, left colon, right colon, and cecum) was measured 3 min before administration (zero time) and at 15, 30, 45, 60, 90, and 120 minutes after administration.
Small and large intestinal motility was within the normal ranges before IV injection of normal isotonic saline or dexmedetomidine at a dose of 3, 5, and 7 μg/kg. Two Way Repeated Measures ANOVA output of the data displayed a statistically significant the between time and treatments for the contractility of each of the duodenum (P = 0.0029), jejunum (P = 0.0033), left colon (P = 0.0073), right colon (P = 0.0035), and cecum (P = 0.0026), implying that the impact of treatment on the gastric motility varied among different time points. The simple main effect analysis revealed that the IV dexmedetomidine at 3, 5, and 7 μg/kg doses significantly inhibited (P ≤ 0.01) the bowel contractility compared to the administration of isotonic saline.
Dose-dependent inhibitory effect of dexmedetomidine on intestinal motility was reported in donkeys following intravenous administration. This inhibitory effect on intestinal motility should be considered in clinical practice.
不同剂量右美托咪定对驴的胃肠道影响仍不清楚。本研究旨在通过经腹超声评估不同剂量右美托咪定对驴胃肠道特定部位运动的影响。
对 30 匹(15 公 15 母)健康雌雄驴(160±60kg)进行了一项实验性交叉研究。在两周洗脱期后,每头驴分别静脉注射生理盐水或三种不同剂量右美托咪定(分别为 3、5 和 7μg/kg)。所有药物均以相等体积静脉注射。在给药前 3 分钟(零时间)和给药后 15、30、45、60、90 和 120 分钟测量选定肠段(十二指肠、空肠、左结肠、右结肠和盲肠)的收缩性。
在静脉注射等渗生理盐水或 3、5 和 7μg/kg 右美托咪定之前,小肠和大肠的运动均在正常范围内。数据的双因素重复测量方差分析输出显示,在十二指肠(P=0.0029)、空肠(P=0.0033)、左结肠(P=0.0073)、右结肠(P=0.0035)和盲肠(P=0.0026)的收缩性方面,时间和处理之间存在统计学上显著的差异,这意味着治疗对胃动力的影响在不同时间点有所不同。简单主要效应分析显示,与生理盐水相比,静脉注射 3、5 和 7μg/kg 右美托咪定显著抑制(P≤0.01)肠道收缩性。
在静脉给药后,驴的肠道运动出现了右美托咪定剂量依赖性抑制作用。在临床实践中应考虑这种对肠道运动的抑制作用。